NANCY RICHMOND: Open Payments
NPI 1770524761 · MARINA DEL REY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,627 in 86 payments from 10 companies in 2025. Trend: 2023 $1,349 · 2024 $2,593 · 2025 $2,627
Food & beverage: $2,335Education: $292
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 19 | $603 |
| Janssen Pharmaceuticals, Inc | 21 | $511 |
| Otsuka America Pharmaceutical, Inc. | 15 | $444 |
| Neurocrine BioSciences, Inc. | 8 | $359 |
| E.R. Squibb & Sons, L.L.C. | 7 | $248 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $221 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Lundbeck LLC | 2 | $66 |
| Alkermes, Inc. | 2 | $55 |
| Luye Pharma (USA) Ltd. | 1 | $23 |
Products named: INVEGA SUSTENNA, UZEDY, INGREZZA, COBENFY, CAPLYTA, REXULTI, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
